Impact of dose‐escalation schemes and drug discontinuation on weight loss outcomes with liraglutide 3.0 mg: A model‐based approach
Author:
Affiliation:
1. Novo Nordisk A/S, Quantitative Clinical Pharmacology Søborg Denmark
2. Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences University of Copenhagen Copenhagen Denmark
Funder
Innovationsfonden
Novo Nordisk
Publisher
Wiley
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.13985
Reference36 articles.
1. WHO recognition of the global obesity epidemic
2. The Epidemiology of Obesity: A Big Picture
3. Global burden of obesity in 2005 and projections to 2030
4. Maintenance of Lost Weight and Long-Term Management of Obesity
5. The global obesity pandemic: shaped by global drivers and local environments
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Liraglutide’s Effect on Weight Management in Subjects With Pre-diabetes: A Systematic Review & Meta-Analysis;Endocrine Practice;2024-08
2. Pharmacological management of testosterone deficiency in men current advances and future directions;Expert Review of Clinical Pharmacology;2024-06-13
3. A model‐based approach to predict individual weight loss with semaglutide in people with overweight or obesity;Diabetes, Obesity and Metabolism;2023-07-09
4. Potential contributors to variation in weight‐loss response to liraglutide;Obesity Reviews;2023-04-17
5. Current treatment landscape for obesity in Singapore;Singapore Medical Journal;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3